Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Shenzhen Shunshi Juhe Biotechnology

Request full access

A contributor in the field of early diagnosis of gynecological tumors

Ningbo, ChinaFounded 2020Biotech & Life Sciences

About Shenzhen Shunshi Juhe Biotechnology

Cispoly is dedicated to developing innovative solutions for women's health, with a particular focus on early oncological diagnosis and cervical cancer screening. The company collaborates with medical associations and hospitals to conduct cutting-edge research, such as studies on DNA methylation in gynecological screening. Cispoly's business model revolves around identifying real clinical needs, understanding them through creative thinking, and meeting them with practical solutions that benefit a broader population. The company operates in the healthcare market, specifically targeting women's health, and generates revenue through the development and sale of diagnostic tools and screening services. By prioritizing long-term product strategies and leveraging innovation, Cispoly aims to become a leading brand in early cancer diagnosis.

Source: Dealroom company data

At a glance

Status
Operational
Employees
4
Open positions
None listed
Dealroom signal
25.3/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Oncology, Health Diagnostics, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Dec 2023 $28M $110M Sunland fund · Prosperity7 Ventures ↗
SERIES A✓Equity / VC Apr 2022 $14M $55M Haibang Capital —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Shenzhen Shunshi Juhe Biotechnology website traffic

Latest recorded traffic for Shenzhen Shunshi Juhe Biotechnology is 220 monthly website visits, up 0% over the last three months. Shenzhen Shunshi Juhe Biotechnology's team grew 0% over the past year.

Latest monthly visits220 3-month web change0% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Shenzhen Shunshi Juhe Biotechnology in the Ningbo ecosystem

Live from Dealroom

The Shenzhen Shunshi Juhe Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

Series A3 investors entered at this stage

  • Haibang Capital
  • Sunland fund
  • Prosperity7 Ventures
Employees 4 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Shenzhen Shunshi Juhe Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Shenzhen Shunshi Juhe Biotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.